ArticleEndocrine2026
Bidirectional risk stratification of calcium disturbances after parathyroidectomy in dialysis patients with secondary hyperparathyroidism: development and validation of a multinomial nomogram.
Article in Endocrine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeWe constructed a multinomial nomogram to predict postoperative hypocalcemia and hypercalcemia following parathyroidectomy (PTX) in dialysis patients with secondary hyperparathyroidism (SHPT).
methodsWe analyzed 685 dialysis patients undergoing PTX between January 2013 and May 2025. Patients were randomly allocated into a training cohort (n = 479) and a validation cohort (n = 206) in a 7:3 ratio. Independent predictors of postoperative calcium levels were identified using a multinomial logistic regression model. Model performance was internally validated using 200 bootstrap resamples and assessed by the area under the receiver operating characteristic curve (AUC), calibration curves, and decision curve analysis (DCA).
resultsPostoperative hypocalcemia occurred in 21.2% (n = 144) of patients, while 10.5% (n = 72) developed hypercalcemia. The final nomogram incorporated seven clinical variables: gender, dialysis duration, preoperative serum calcium, parathyroid hormone (PTH), alkaline phosphatase (ALP), C-terminal telopeptide (CTX), and intraoperative PTH (ioPTH). The nomogram demonstrated excellent discrimination, achieving a macro-AUC of 0.87 (95% CI: 0.84, 0.90) in the training set and 0.81 (95% CI: 0.76, 0.86) in the validation set. Calibration curves exhibited concordance between predicted probabilities and actual outcomes, and DCA confirmed that the model provides a clinical net benefit across probability thresholds of 0 to 0.45 for both abnormal calcium states.
conclusionsThis nomogram accurately stratifies the risk of bidirectional calcium disturbances in SHPT patients, empowering clinicians to optimize perioperative monitoring and individualized supplementation strategies.
Indexed as
Identifiers
42228291What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.